Adebrelimab With or Without SHR-8068 in Combination With Cisplatin Plus Gemcitabine as First-line Treatment in Patients With Advanced Biliary Tract Cancer

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions

Biliary Tract Cancer

Interventions

DRUG

SHR-8068

DRUG

Adebrelimab

DRUG

Cisplatin

DRUG

Gemcitabine

Trial Locations (1)

RECRUITING

The First Affiliated Hospital，Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors

lead

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

INDUSTRY